Dental 3D Printing Solution Provider Secures Over 100 Million CNY in Series A Financing, with Rayshape’s Global Agent Network Exceeding 100

PanDen 2024-10-26 01:07 Business

Panda3dp.com Guide: The model of offering 3D printing equipment for free while recouping costs and generating profit through the sale of 3D printing resin materials has been widely adopted by numerous companies in the dental industry. Among them, Rayshape(铼赛智能) has emerged as one of the fastest-growing companies in the past two years.

On October 24, 2024, dental 3D printing solutions provider Suzhou Rayshape announced the completion of a Series A financing round exceeding 100 million CNY. The round was led by Sharelink Capital(协立投资), with participation from several seasoned entrepreneurs in the dental industry. Index Capital(指数资本) acted as the exclusive financial advisor, and the funds will primarily be used for capacity expansion and market expansion overseas.

△ Rayshape at 2024 Formnext

China's digital medical development has been elevated to a national strategic level, with dental digitization being a critical component of overall medical digitization. 3D printing technology is widely applied in various aspects such as dental restoration, implants, and the manufacturing of orthodontic devices, continuously expanding the digital dental application landscape and guiding the transformation of labor-intensive manufacturing toward intelligent manufacturing. Currently, 3D printing solutions for dentistry offer advantages such as customization, low waste, and high precision, and are transitioning from an optional to a necessary choice. According to SmarTech data, in 2021, the dental 3D printing market reached $3.5 billion, and it is expected to grow to $9 billion globally by 2028.

Rayshape is a provider of integrated digital production solutions based on 3D printing. Led by a founding team with over 10 years of experience in the 3D printing industry, boasting a comprehensive skill set, deep technological expertise, and a mature operational philosophy, the company possesses full, independent R&D capabilities across the entire chain, from optical, electrical, mechanical, software, and algorithmic solutions to material development, including AI-based design solutions and material research. They offer leading, fully integrated solutions covering 3D printing equipment, software, materials, and technical services for various industries and application scenarios.

Comprehensive Product Portfolio Covering Equipment, Software, Materials, and End-Products

Rayshape’s offerings include a range of 3D printing equipment under the Shape, P, and Edge series, as well as more than 20 high-performance photosensitive resin materials and end-products, tailored to sectors such as industrial design, electronics, digital dentistry, and cultural and creative industries. These products provide comprehensive solutions and deployment services across multiple application directions.

In terms of equipment, Rayshape’s current flagship models include the Shape 1+Dental, Edge E2, and Edge Max, which cater to different needs in dental clinics and laboratories, offering a gradient of choices in terms of size, speed, and precision. These products stand out for their high reliability, accuracy, cost-effectiveness, and user-friendliness, rapidly capturing a significant share of the global dental 3D printing market.

Additionally, Rayshape has independently developed over 20 specialized resin materials for dental applications, with some products receiving NMPA/FDA approval and others in the process of applying for Class III medical device registration. Their custom 3D-printed soft tissue scaffolds are poised to become the next-generation solution for edentulous jaws. Looking ahead, Rayshape plans to accelerate its strategic initiatives in the areas of invisible dentures and permanent teeth, driving innovative transformations in the field of restorative dentistry.

Global Customer Ecosystem and Cross-Sector Collaboration

Thanks to its comprehensive product portfolio and competitive advantages, Rayshape has established a presence in multiple dental subfields, including leading dental laboratories, top public hospitals, large dental chains, major distribution channels, and prominent brands.

To date, Rayshape has shipped thousands of units and built an extensive portfolio of key customer cases across various sectors. These include major medical device clients like Huawei, Mairui, Lianying, and Yuyue; over a thousand denture processing factories, such as Kangtaijian, Jiahong, Dengte, and Dekaili; and hundreds of dental hospitals and clinics, including West China Hospital of Sichuan University, Wuhan University Stomatological Hospital, RuierDental, and Huanle Dental.

In international markets, Rayshape has focused on countries along the Belt and Road Initiative, steadily advancing its global expansion. The company has established subsidiaries in Europe and the United States, extending its reach to 60 countries, including Europe, North Africa, the Asia-Pacific region, North America, and Central and South America. It has also partnered with more than 120 overseas companies, such as Viet Dang, Novadent, and Unident, with overseas revenue continuing to grow.

Strong Team Recognized by Investors

Rayshape’s founder and CEO, Liu Zhen, previously served as R&D director at a leading domestic 3D printing equipment manufacturer, where he was responsible for product line development and operational management. The team’s leaders in technology, materials, algorithms, and application services have extensive professional experience in fields such as 3D printing, electromechanics, and photopolymer materials, along with deep expertise in digital dentistry and global business acumen. This rare, highly capable team, with its rich technological foundations, has earned unanimous recognition from investors.

"Sharelink Capital has consistently focused on the innovative applications of 3D printing technology, with the dental industry emerging as one of its most promising commercial avenues. This technology is reshaping the oral healthcare ecosystem, delivering a more comfortable patient experience, streamlining diagnosis and treatment processes, and offering cost-effective, personalized dental prosthetics. Riding the wave of digitalization in dentistry, the market potential for 3D printing equipment and materials is immense. We highly value the excellent product capabilities and operational efficiency of the Raise team. The company's rapid growth in shipments of equipment and materials positions it to continue as a leader in this niche sector."
— Lead investor of this funding round, Sharelink Capital

"We have always closely followed the innovative technologies within the consumer healthcare sector. As a new form of productivity, 3D printing serves as a prime example of how cutting-edge advancements are transforming traditional production and relationships across various industrial chains. The highly customized nature of the dental industry makes it the fastest to achieve commercialization of 3D printing within the medical field. We greatly admire Raise's product development philosophy, delivering high-quality products that merge industrial-grade technology with consumer-level affordability. Through technological innovation, they bring superior product experiences to a broader range of industry users. We believe that in the future, Raise will emerge as a global leader in 3D printing, driving the next wave of transformation in the dental industry."
— Chen Ge, Senior Vice President of Index Capital

△2024 Shenzhen Formnext 3D Printing Exhibition: Panda3dp.com's Exclusive Interview with Rayshape

Another Metal 3D Printing Manufacturer Undergoes Shareholding Reform: TSC Laser Technology Co., Ltd. Formally Established BCX Achieves Over 5,000 Installations of 3D Printing Lasers; Domestic Core Components See Widespread Application